Ambalal Sarabhai Enterprises Stock Falls to 52-Week Low of Rs.28.1

Dec 01 2025 11:25 AM IST
share
Share Via
Ambalal Sarabhai Enterprises has reached a new 52-week low of Rs.28.1, marking a significant decline in its stock price amid broader market gains. This development highlights ongoing concerns surrounding the company’s financial performance and valuation within the Pharmaceuticals & Biotechnology sector.



Stock Price Movement and Market Context


On 1 Dec 2025, Ambalal Sarabhai Enterprises touched Rs.28.1, its lowest price in the past year. This level contrasts sharply with its 52-week high of Rs.68, reflecting a near 59% reduction over the period. Despite the stock’s recent outperformance relative to its sector by 1.03% on the day of the low, it remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning indicates sustained downward pressure on the stock price over multiple time horizons.



Meanwhile, the broader market environment has shown resilience. The Sensex opened higher at 86,065.92, gaining 359.25 points (0.42%) before trading slightly lower at 85,861.27 (0.18%). The index is within 0.23% of its 52-week high of 86,055.86 and has recorded a three-week consecutive rise, accumulating a 1.54% gain. The Sensex’s 50-day moving average remains above its 200-day moving average, signalling a bullish trend. Additionally, the BSE Small Cap index gained 0.4%, leading market segments on the day.



Financial Performance and Valuation Metrics


Ambalal Sarabhai Enterprises’ financial data over the past year reveals challenges in both profitability and growth. The company’s net sales have grown at an annual rate of 7.00% over the last five years, a modest pace relative to sector peers. Its average Return on Capital Employed (ROCE) stands at 4.55%, indicating limited efficiency in generating returns from capital investments.



Recent quarterly results show a Profit Before Tax (PBT) of Rs. -1.66 crore, representing a decline of 548.6% compared to the previous four-quarter average. The Profit After Tax (PAT) for the quarter was Rs. -0.56 crore, down by 111.3% relative to the same benchmark. Operating cash flow for the year registered a negative Rs.17.62 crore, the lowest level recorded, signalling cash utilisation pressures.




Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.



  • - Investment Committee approved

  • - 50+ candidates screened

  • - Strong post-announcement performance


See Why It Was Chosen →




Comparative Performance and Market Position


Over the last year, Ambalal Sarabhai Enterprises has generated a return of -49.97%, significantly underperforming the Sensex, which recorded a 7.61% gain over the same period. The stock has also lagged behind the BSE500 index across the last three years, one year, and three months, reflecting persistent underperformance relative to broader market benchmarks.



Despite these challenges, the company’s valuation metrics suggest some degree of market discount. The ROCE of 1.5 and an Enterprise Value to Capital Employed ratio of 1.4 indicate that the stock is trading at a lower valuation compared to its peers’ historical averages. Additionally, the company’s profits have risen by 24.8% over the past year, with a Price/Earnings to Growth (PEG) ratio of 0.5, which may reflect market expectations of subdued growth prospects.



Shareholding and Sectoral Context


The majority of Ambalal Sarabhai Enterprises’ shares are held by non-institutional investors, which may influence trading dynamics and liquidity. The company operates within the Pharmaceuticals & Biotechnology sector, a segment that has seen mixed performance amid evolving market conditions and sector-specific developments.




Ambalal Sarabhai Enterprises or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Summary of Key Indicators


Ambalal Sarabhai Enterprises’ stock price at Rs.28.1 represents a critical low point within the last 52 weeks, underscoring the company’s ongoing valuation and performance challenges. The stock’s position below all major moving averages suggests continued caution among market participants. Meanwhile, the broader market and sector indices have shown relative strength, with the Sensex nearing its 52-week high and small caps leading gains.



Financially, the company’s subdued sales growth, low ROCE, and negative cash flow figures highlight areas of concern. The recent quarterly losses and negative profit margins further illustrate the pressures faced. However, valuation metrics indicate the stock is trading at a discount relative to peers, reflecting the market’s current assessment of its prospects.



Investors and market watchers will note the divergence between Ambalal Sarabhai Enterprises’ stock performance and the broader market’s upward trend, emphasising the importance of monitoring sector-specific developments and company fundamentals closely.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News